TrialNature medicine2024

Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial.

Scott Kopetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.